James M Daly is of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 20,503 shares of HALO, which is worth approximately $962,820. The most recent transaction as insider was on Aug 14, 2023, when has been sold 10,000 shares (Common Stock) at a price of $43.74 per share, resulting in proceeds of $437,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.5K
0% 3M change
0% 12M change
Total Value Held $962,820

James M Daly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2023
SELL
Open market or private sale
$437,400 $43.74 p/Share
10,000 Reduced 32.78%
20,503 Common Stock
Aug 11 2023
SELL
Open market or private sale
$437,100 $43.71 p/Share
10,000 Reduced 24.69%
30,503 Common Stock
May 05 2023
BUY
Grant, award, or other acquisition
-
8,065 Added 16.61%
40,503 Common Stock
May 05 2022
BUY
Grant, award, or other acquisition
-
6,206 Added 16.06%
32,438 Restricted Stock Unit
May 05 2021
BUY
Grant, award, or other acquisition
-
5,230 Added 16.62%
26,232 Restricted Stock Unit
Nov 25 2020
SELL
Open market or private sale
$418,769 $40.41 p/Share
10,363 Reduced 33.04%
21,002 Common Stock

Also insider at

BLCM
BELLICUM PHARMACEUTICALS, INC Healthcare
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
JMD

James M Daly

Houston, TX

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO